Qiuchen Guo

Qiuchen Guo is a Scientist in Discovery at Candel Therapeutics, with experience since March 2022. Prior to this role, Qiuchen served as a Postdoctoral Researcher at Brigham and Women's Hospital from July 2017 to March 2022. Qiuchen holds a Doctor of Philosophy in Cancer Biology from Oregon Health & Science University, completed in 2017, and a Certificate in Applied Biostatistics from The Harvard Catalyst Education Program, earned in 2019. Initial education includes transferring from the University of Colorado Anschutz Medical Campus as a PhD candidate in cancer biology in 2014, and a Bachelor of Science in Biotechnology obtained from the University of Science and Technology of China in 2010.